Familiar Names To Top US FDA's Reorganized Cardiovascular Devices Office

Companies that have brought products through US FDA's current cardiac device review office will come across many of the same review managers in the newly forming Office of Cardiovascular Devices, which will also include a few compliance and surveillance officers on the leadership team. The new office will sit within the device center's nascent "total product lifecycle" Office of Product Evaluation and Quality.